These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6934330)

  • 21. [The sorption effectiveness of Czech-manufactured hemoperfusion sorbents for amatoxins].
    Monhart V; Balíková M; Tlust'áková M
    Cas Lek Cesk; 1994 Mar; 133(6):181-3. PubMed ID: 8156574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of digoxin poisonings.
    Fraser DG; Ludden TM
    Am J Hosp Pharm; 1978 Sep; 35(9):1030-1. PubMed ID: 696738
    [No Abstract]   [Full Text] [Related]  

  • 23. Digoxin removal from a patient with renal failure by hemoperfusion with Amberlite XAD-4 resin.
    Hoy W; Gibson TP; Biddle T
    Artif Organs; 1979 May; 3(2):124-6. PubMed ID: 533394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Digoxin overdose. Limitations of hemoperfusion-hemodialysis treatment.
    Warren SE; Fanestil DD
    JAMA; 1979 Nov; 242(19):2100-1. PubMed ID: 490791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemoperfusion for acute drug intoxication.
    Rosenbaum JL
    Kidney Int Suppl; 1980 Sep; 10():106-8. PubMed ID: 6934345
    [No Abstract]   [Full Text] [Related]  

  • 26. [Case of acute digoxin and digitoxin poisoning].
    Lukoshevichiute AI; Grutsite VR
    Anesteziol Reanimatol; 1977; (5):76-7. PubMed ID: 920988
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemoperfusion with alpha-amanitin: an in vitro study.
    Mydlík M; Derzsiová K; Klán J; Zíma T
    Int J Artif Organs; 1997 Feb; 20(2):105-7. PubMed ID: 9093889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum digoxin and digitoxin determinations.
    Taylor DG
    J Tenn Med Assoc; 1974 Jul; 67(7):586. PubMed ID: 4845585
    [No Abstract]   [Full Text] [Related]  

  • 29. [Incidence and extent of digitalis-induced disorders of color vision. A comparative study of subtoxic and toxic digoxin and digitoxin serum concentrations].
    Horst HA; Kolenda KD; Duncker G; Schenck F; Löffler H
    Med Klin (Munich); 1988 Sep; 83(17):541-7. PubMed ID: 3262815
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemoperfusion with Amberlite resin in the treatment of self-poisoning.
    Heath A; Delin K; Edén E; Mårtensson E; Selander D; Wickström I; Ahlmén J
    Acta Med Scand; 1980; 207(6):455-60. PubMed ID: 7424564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemoperfusion study with carbamazepine in vitro.
    Derzsiová K; Mydlík M; Petríková V
    Int J Artif Organs; 1999 Nov; 22(11):730-3. PubMed ID: 10612298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemoperfusion in chronic uremia.
    Stefoni S; Feliciangeli G; Cianciolo G; De Sanctis LB; Giardino R; Spighi M
    Boll Soc Ital Biol Sper; 1993 Nov; 69(11):675-82. PubMed ID: 8060597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of digitoxin overdose with oral activated charcoal.
    Pond S; Jacobs M; Marks J; Garner J; Goldschlager N; Hansen D
    Lancet; 1981 Nov; 2(8256):1177-8. PubMed ID: 6118621
    [No Abstract]   [Full Text] [Related]  

  • 34. Microencapsulated charcoal hemoperfusion: a possible therapeutic adjunct in digoxin toxicity.
    Prichard S; Chirito E; Chang T; Sniderman AD
    J Dial; 1977; 1(4):367-77. PubMed ID: 608859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasmaperfusion through activated charcoal and amberlite XAD-7 in dogs with liver failure induced by yellow phosphorus (author's transl)].
    Horak W; Polterauer P; Renner F; Silberbauer K; Rauhs R; Mühlbacher F; Funovics J
    Z Gastroenterol; 1979 Feb; 17(2):90-8. PubMed ID: 425590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Plasma concentration of digoxin and digitoxin in elderly : correlation with clinical toxicity (author's transl)].
    Scherrmann JM; Venet R; Maire A; Memin Y; Bourdon R
    Therapie; 1981; 36(1):11-20. PubMed ID: 7233367
    [No Abstract]   [Full Text] [Related]  

  • 37. Hemoperfusion for methotrexate removal.
    Gibson TP; Reich SD; Krumlovsky FA; Ivanovich P; Gonczy C
    Clin Pharmacol Ther; 1978 Mar; 23(3):351-5. PubMed ID: 627142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of activated charcoal on digoxin and digitoxin clearance.
    Park GD; Goldberg MJ; Spector R; Johnson GF; Feldman RD; Quee CK; Roberts P
    Drug Intell Clin Pharm; 1985 Dec; 19(12):937-41. PubMed ID: 4085353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemoperfusion in the management of digoxin toxic reaction.
    Risler T; Grabensee B
    JAMA; 1979 Sep; 242(11):1140. PubMed ID: 470060
    [No Abstract]   [Full Text] [Related]  

  • 40. Removal of digoxin by column for specific adsorption of beta(2)-microglobulin: a potential use for digoxin intoxication.
    Tsuruoka S; Osono E; Nishiki K; Kawaguchi A; Arai T; Furuyoshi S; Saito T; Takata S; Sugimoto K; Kurihara S; Fujimura A
    Clin Pharmacol Ther; 2001 Jun; 69(6):422-30. PubMed ID: 11406739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.